Cargando…
Immunomodulation with IL-7 and IL-15 in HIV-1 infection
Immunomodulating agents are substances that modify the host immune responses in diseases such as infections, autoimmune conditions and cancers. Immunomodulators can be divided into two main groups: 1) immunostimulators that activate the immune system such as cytokines, toll-like receptor agonists an...
Autores principales: | Gunst, Jesper D., Goonetilleke, Nilu, Rasmussen, Thomas A., Søgaard, Ole S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520363/ https://www.ncbi.nlm.nih.gov/pubmed/37767312 http://dx.doi.org/10.1016/j.jve.2023.100347 |
Ejemplares similares
-
Fimepinostat, a novel dual inhibitor of HDAC and PI3K,
effectively reverses HIV-1 latency ex vivo without T cell activation
por: Gunst, Jesper D, et al.
Publicado: (2019) -
Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure
por: Goonetilleke, Nilu, et al.
Publicado: (2019) -
The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies
por: Martinsen, Janne Tegder, et al.
Publicado: (2020) -
The immune response during acute HIV-1 infection: clues for vaccine development
por: McMichael, Andrew J., et al.
Publicado: (2009) -
Effect of IL-7 and IL-15 on T cell phenotype in myelodysplastic syndromes
por: Dong, Wen, et al.
Publicado: (2016)